Literature DB >> 20661118

Reticulated myxoid tumor of the tongue: 2 cases supporting an expanded clinical and immunophenotypic spectrum of ectomesenchymal chondromyxoid tumor of the tongue.

Sang Hee Seo1, Dong Hoon Shin, Hyun Jeong Kang, Kyung Un Choi, Jee Yeon Kim, Do Youn Park, Chang Hun Lee, Mee Young Sol, Jin Choon Lee.   

Abstract

An ectomesenchymal chondromyxoid tumor (ECMT) is a rare neoplasm that exclusively occurs in the anterior dorsum of the tongue. The tumor consists of small round to fusiform or spindle cells with myxoid or chondroid stroma. The tumor consistently shows a positive reaction with glial fibrillary acidic protein antibodies, especially polyclonal antibodies. We report 2 cases of reticulated myxoid tumors arising in the tongue. One tumor occurred in the posterior dorsum of the tongue and another in the anterior. Both tumors showed characteristic morphology of ECMT; however, both were negative for reactions with monoclonal and polyclonal glial fibrillary acidic protein antibodies. On the basis of morphology, they are thought to be belonging to ECMT. Hence, we suggest that ECMT can show broader spectrum of clinical and immunophenotypic feature.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661118     DOI: 10.1097/DAD.0b013e3181d7d3bf

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  10 in total

1.  A case of a CD56-expressing ectomesenchymal chondromyxoid tumor of the tongue: potential diagnostic usefulness of commonly available CD56 over CD57.

Authors:  Shogo Tajima; Kenji Koda
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Ectomesenchymal Chondromyxoid Tumor: A Neoplasm Characterized by Recurrent RREB1-MKL2 Fusions.

Authors:  Brendan C Dickson; Cristina R Antonescu; Prokopios P Argyris; Elizabeth A Bilodeau; Martin J Bullock; Paul D Freedman; Douglas R Gnepp; Richard C Jordan; Ioannis G Koutlas; Cheng-Han Lee; Iona Leong; Mihai Merzianu; Bibianna M Purgina; Lester D R Thompson; Bret Wehrli; John M Wright; David Swanson; Lei Zhang; Justin A Bishop
Journal:  Am J Surg Pathol       Date:  2018-10       Impact factor: 6.394

Review 3.  Ectomesenchymal Chondromyxoid Tumor: A Series of Seven Cases and Review of the Literature.

Authors:  Abdulaziz Aldojain; Jumana Jaradat; Kurt Summersgill; Elizabeth A Bilodeau
Journal:  Head Neck Pathol       Date:  2014-11-18

4.  Ectomesenchymal chondromyxoid tumour of the posterior tongue.

Authors:  Marie-Josée Cardin; Pierre Olivier Fiset; Anthony G Zeitouni; Derin Caglar
Journal:  Head Neck Pathol       Date:  2013-11-28

5.  Expanding Awareness of the Distribution and Biologic Potential of Ectomesenchymal Chondromyxoid Tumor.

Authors:  Justin Bubola; Klieb Hagen; Nick Blanas; Ilan Weinreb; Brendan C Dickson; Tra Truong
Journal:  Head Neck Pathol       Date:  2020-05-05

6.  Ectomesenchymal chondromyxoid tumor: Review of literature and a report of a rare case.

Authors:  Mohanty Leeky; Tv Narayan; Sadhana Shenoy; Saleha Jamadar
Journal:  J Oral Maxillofac Pathol       Date:  2011-01

7.  Ectomesenchymal Chondromyxoid Tumour of the Dorsal Tongue Presenting with Impaired Speech.

Authors:  Laura A Schep; Martin J Bullock; S Mark Taylor
Journal:  Case Rep Otolaryngol       Date:  2016-04-28

Review 8.  Ectomesenchymal chondromyxoid tumor: a comprehensive updated review of the literature and case report.

Authors:  Astrid Truschnegg; Stephan Acham; Lumnije Kqiku; Norbert Jakse; Alfred Beham
Journal:  Int J Oral Sci       Date:  2018-02-28       Impact factor: 6.344

9.  Ectomesenchymal chondromyxoid neoplasm. An unusual presentation. A case report.

Authors:  Hussein Ali AlZamel; Abdulmohsen AlBader; Imtiyaz Nawaz Bhat
Journal:  Int J Surg Case Rep       Date:  2017-10-25

10.  Ectomesenchymal chondromyxoid tumor in the anterior tongue: case report of a unique tumor.

Authors:  Min Gyoung Pak; Kyung Bin Kim; Nari Shin; Woo Kyung Kim; Dong Hoon Shin; Kyung Un Choi; Mee Young Sol
Journal:  Korean J Pathol       Date:  2012-04-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.